Gupta Jitendra, Gupta Reena
Institute of Pharmaceutical Research, GLA University, Mathura 281406, Uttar Pradesh, India.
Curr Drug Targets. 2023;24(3):274-286. doi: 10.2174/1389450124666221220165137.
With a prevalence ranging from 16-21%, tinnitus is an irking neurological disorder, manifesting as the perception of a roar of cacophony without an external acoustic stimulus. Although tinnitus is a non-life-threatening symptom, tinnitus's negative repercussions, such as personality disturbances and social withdrawal, are daunting concerns despite a gamut of conventional and emerging treatment options. Tinnitus management is still a critical challenge that provides opportunities for clinicians, ENT (Ear/eye, nose and throat) physicians, and other specialists such as audiologists, psychiatrists, and psychologists. Among the new treatment modalities, Neuromonics tinnitus treatment (NTT) draws special attention in tinnitus management due to its mounting success rate. Nonetheless, unlike in developed countries like Australia, the United States, and the United Kingdom, the scanty awareness of NTT among Indian ENT specialists is a titanic setback for care providers. Because of this backdrop, this review emphasized the current perspectives on tinnitus management and the underlying principles and clinical efficacy of NTT. The challenges for tinnitus management can be met and reduced by suppressing tinnitus through motivation, counseling, cochlear implant, and psychotherapy.
耳鸣的患病率在16%-21%之间，是一种令人苦恼的神经系统疾病，表现为在没有外部声学刺激的情况下感觉到嘈杂的轰鸣声。尽管耳鸣不是危及生命的症状，但尽管有一系列传统和新兴的治疗选择，耳鸣的负面影响，如性格障碍和社交退缩，仍然是令人担忧的问题。耳鸣管理仍然是一项严峻的挑战，为临床医生、耳鼻喉科（耳/眼、鼻和喉）医生以及听力学家、精神科医生和心理学家等其他专家提供了机会。在新的治疗方式中，Neuromonics耳鸣治疗（NTT）因其不断提高的成功率而在耳鸣管理中受到特别关注。然而，与澳大利亚、美国和英国等发达国家不同，印度耳鼻喉科专家对NTT的了解甚少，这对医疗服务提供者来说是一个巨大的挫折。鉴于此背景，本综述强调了耳鸣管理的当前观点以及NTT的基本原则和临床疗效。通过激励、咨询、人工耳蜗植入和心理治疗来抑制耳鸣，可以应对和减少耳鸣管理的挑战。
